[1]
Di Lena, M. et al. 2017. Mirabegron as adjuvant treatment for patients with interstitial cystitis/bladder pain syndrome. Canadian Urological Association Journal. 12, 3 (Dec. 2017), E100–4. DOI:https://doi.org/10.5489/cuaj.4325.